Stock Analysis on Net
Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

Debt to Equity
since 2005

Microsoft Excel

Paying user area

Try for free

Boston Scientific Corp. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Boston Scientific Corp., debt to equity, long-term trends, calculation

Microsoft Excel
Debt to equity = Total debt1 ÷ Stockholders’ equity1
Dec 31, 2022 = ÷
Dec 31, 2021 = ÷
Dec 31, 2020 = ÷
Dec 31, 2019 = ÷
Dec 31, 2018 = ÷
Dec 31, 2017 = ÷
Dec 31, 2016 = ÷
Dec 31, 2015 = ÷
Dec 31, 2014 = ÷
Dec 31, 2013 = ÷
Dec 31, 2012 = ÷
Dec 31, 2011 = ÷
Dec 31, 2010 = ÷
Dec 31, 2009 = ÷
Dec 31, 2008 = ÷
Dec 31, 2007 = ÷
Dec 31, 2006 = ÷
Dec 31, 2005 = ÷

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions

Total Debt
The total debt exhibited a fluctuating trend over the observed period. Starting at 2,020 million USD in 2005, it rose sharply to a peak of 9,124 million USD in 2006. Subsequently, total debt decreased steadily over the next several years, reaching a low of 4,240 million USD by 2012. From 2013 onward, the debt levels showed a general upward trajectory, peaking at 10,008 million USD in 2019. Since then, the total debt decreased gradually, ending at 8,935 million USD by 2022.
Stockholders’ Equity
Stockholders' equity started at 4,282 million USD in 2005 and increased significantly to 15,298 million USD in 2006. After that peak, equity declined moderately and fluctuated around 11,000 to 13,000 million USD until 2011. A notable drop occurred in 2012 and 2013, with the equity falling to approximately 6,539 million USD in 2013. Following this period, equity showed a consistent and strong recovery, rising steadily from 6,457 million USD in 2014 to 17,573 million USD in 2022.
Debt to Equity Ratio
The debt to equity ratio indicates the company's leverage and financial risk. Starting at 0.47 in 2005, the ratio increased to 0.60 in 2006 before gradually declining to a low of 0.38 in 2011. After 2011, the ratio rose again, reaching values around 0.8 to 0.9 between 2013 and 2016. From 2017 onward, the ratio decreased steadily, reaching 0.51 in 2022, indicating a movement towards lower leverage relative to equity by the end of the period.
Overall Analysis
The data reveal periods of financial restructuring, with significant increases and decreases in both debt and equity at different times. The sharp rise in debt and equity in 2006 suggests possible financing activities or acquisitions. The subsequent decline in equity in 2012-2013 alongside increased leverage points to financial challenges or strategic shifts. However, the recovery in equity and reduction in leverage ratio from 2014 onward indicate an improving financial position and reduced reliance on debt. The downward trend in the debt to equity ratio in the recent years reflects a strengthening equity base relative to debt, which is generally a positive sign for financial stability.

Comparison to Competitors

Boston Scientific Corp., debt to equity, long-term trends, comparison to competitors

Microsoft Excel
Boston Scientific Corp. Abbott Laboratories CVS Health Corp. Elevance Health Inc. Intuitive Surgical Inc. Medtronic PLC UnitedHealth Group Inc.
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Dec 31, 2014
Dec 31, 2013
Dec 31, 2012
Dec 31, 2011
Dec 31, 2010
Dec 31, 2009
Dec 31, 2008
Dec 31, 2007
Dec 31, 2006
Dec 31, 2005

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Health Care Equipment & Services)

Boston Scientific Corp., debt to equity, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel
Boston Scientific Corp. Health Care Equipment & Services
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Dec 31, 2014
Dec 31, 2013
Dec 31, 2012
Dec 31, 2011
Dec 31, 2010
Dec 31, 2009
Dec 31, 2008
Dec 31, 2007
Dec 31, 2006
Dec 31, 2005

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Boston Scientific Corp., debt to equity, long-term trends, comparison to industry (health care)

Microsoft Excel
Boston Scientific Corp. Health Care
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Dec 31, 2014
Dec 31, 2013
Dec 31, 2012
Dec 31, 2011
Dec 31, 2010
Dec 31, 2009
Dec 31, 2008
Dec 31, 2007
Dec 31, 2006
Dec 31, 2005

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).